Asacol Antitrust Trial to Begin January 22, 2018
Following the November 9th opinion of the Hon. Judge Denise J. Casper’s denial of summary judgement and certification of the class, the case of In re: Asacol Antitrust Litigation, Case No.: 1:15-cv-12730-DJC will proceed to trial on Monday, January 22nd at 8:45 a.m. EST. The trial will be held at the United States District Court for the District of Massachusetts, 1 Courthouse Way Boston, Massachusetts 02210.
Warner Chilcott, the Allergan subsidiary and manufacturer of Asacol, is accused of using an alleged unlawful anticompetitive “product hop” scheme to prevent a generic version of Asacol 400mg from reaching the market, thus preserving its monopoly profits on a “new” patent-protected drug—Delzicol.
Plaintiffs in this case are represented by Wexler Wallace LLP, Wagstaff & Cartmell LLP, Gustafson Gluek PLLC, and others.